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Cedarville, OH 45314 USA
Polycation Avoidance in Paramecium differs widely from that of Tetrahymena
Introduction
Unicellular eukaryotes are complex systems,
performing all the tasks needed for survival within the
context of a single cell. Protozoans, such as
Tetrahymena and Paramecium, use chemosensory
systems to detect food and to avoid predation.
Both Tetrahymena and Paramecium have been used
as models for studying chemorepellents. Lysozyme,
ATP, and GTP have been found to have
chemorepellent activity in both ciliates. In
Tetrahymena, several PACAP isoforms have been
shown to bind to the same receptor as lysozyme,
indicating that this receptor may be a more general
“polycation receptor” (Keedy et al., 2003). The
polycation receptor in Tetrahymena appears to be a Gprotein linked receptor which activates adenylyl cyclase
and phospholipase C (Keedy et al., 2003).
The lysozyme receptors have been affinity purified
from both Paramecium and Tetrahymena. The
molecular weight of the Tetrahymena protein is
approximately 42 kD, while the molecular weight of the
Paramecium protein is approximately 58 kD (Kuruvilla
and Hennessey, 1998).
In our current study, we examined the hypothesis that
Paramecium have a polycation receptor similar to that
of Tetrahymena. We found that although both
organisms bind similar ligands, there are multiple
differences between the two pathways (see
Conclusions).

Materials and Methods
Tetrahymena thermophila, strain B2086, and
Paramecium tetraurelia, strain nd6, both
generous gifts of T.M. Hennessey (SUNY
Buffalo) were used in this study.

Figure 1. Polycation avoidance in Paramecium and Tetrahymena. Both Paramecium (A) and Tetrahymena (B)
avoid VIP (circles), PACAP 1-27 (squares), PACAP 1-38 (diamonds), PACAP 6-27 (hexagons) and lysozyme (stars).
Each point represents the mean ± SD of three trials. A. The concentration of ligand required for 100% avoidance in
Paramecium is 50 μM VIP, 10 μM for PACAP 1-27 and 1-38, and 0.5 μM for lysozyme. We could not obtain 100%
avoidance with PACAP 6-27 because of its toxicity. The EC50 of these polycations in Paramecium was
approximately 3 μM for VIP, 0.75 μM for all PACAP isoforms, and 0.1 μM for lysozyme. B. The concentration of
ligand required for 100% avoidance in Tetrahymena is 100 μM VIP, 0.1 μM for all PACAP isoforms, and 100 μM for
lysozyme. The EC50 of these polycations in Paramecium was approximately 7.5 μM for VIP, 0.05 μM for all PACAP
isoforms, and 50 μM for lysozyme (see also Keedy et al., 2003).

The Pharmacological Profiles of the Receptor Also Differ Between the Two Organisms
Table 2. Summary of Pharmacological Data in Tetrahymena and Paramecium.
Inhibitor
GDP-β-S
GP-Antagonist-2 (BIOMOL™)
Rp-cAMPs
Neomycin Sulfate

Tetrahymena
Inhibits at 1 mM1
Toxic to cells

U-73122
Genistein
Daidzein

Inhibits at 1 μM2
No effect on avoidance at 100 μg/ml1
No effect on avoidance at 100 μg/ml1

1Keedy

Inhibits at 50 μM1
Inhibits at 5 μM1

Paramecium
No effect on avoidance at 1 mM3
No effect on avoidance at 100 μM3
No effect on avoidance at 100 μM3
Inhibits electrophysiological response to
lysozyme at
10 μM4
Toxic to cells3
Inhibits at 0.1 μg/ml3
No effect on avoidance at 100 μg/ml3

et al., 2003. 2Bartholomew et al., unpublished data 3Robinette and Kuruvilla, unpublished data 4Hennessey et al., 1995

The Tyrosine Kinase Inhibitor, Genistein,
Genistein, Eliminates Lysozyme Avoidance in Paramecium

Behavioral studies were conducted as described
by Hennessey et al., 1995. Briefly, individual
cells were transferred from buffer into the
polycation of interest, under a dissection
microscope. Cells were then observed to
determine whether backward swimming
occurred. Ten cells were observed for each trial.
At least three trials were done for each
concentration point.
When inhibitors were used, cells were exposed
to the inhibitor for one to two hours prior to
exposure to the polycation of interest in order to
allow for uptake of the inhibitor.

CrossCross-Adaptation between lysozyme and members
of the PACAP family suggest that these ligands use
the same receptor and/or second messenger
pathway.

Table 1. Cells were adapted to either 0.5 μM lysozyme or 50 μM VIP
for 15 minutes prior to exposure to 0.5 μM lysozyme, 50 μM VIP,
10 μM PACAP 1-38, or 10 μM PACAP 1-27. Cells were not adapted to
any of the PACAP isoforms because prolonged exposure to high
concentrations of PACAP is lethal to Paramecium. Each trial
represents 10 cells. A minimum of three trials was conducted for each
concentration. These data are similar to results previously obtained for
Tetrahymena (Keedy et al., 2003)

Lysozyme
VIP

Lysozyme

PACAP 1-38

PACAP 1-27

VIP

15 ± 5%,
N=4
15 ± 5%,
N=6

20 ± 10%,
N=3
6.6 ± 5.8%,
N=3

20 ± 10%,
N=3
16.6 ± 5.8%,
N= 3

23.3 ± 5.8%,
N=3
10 ± 0%,
N=3

Conclusions
•The polycation receptor of Paramecium appears to have a higher
affinity for lysozyme than for PACAP, while the polycation receptor of
Tetrahymena has a higher affinity for PACAP than for lysozyme, as
indicated by behavioral studies.
•Both receptors have a relatively low affinity for VIP, as indicated by
behavioral studies.
•Both organisms show cross-adaptation between the various
polycations tested (lysozyme, PACAP, VIP), indicating that a single
receptor is probably interacting with all of these polycations.
•In Tetrahymena, pharmacological studies indicate that the polycation
receptor is a G-protein linked receptor. However, in this study, Gprotein inhibitors failed to have any effect on lysozyme avoidance in
Paramecium.
•Paramecium avoidance to lysozyme is inhibited by the tyrosine kinase
inhibitor, genistein. This inhibitor has no effect on lysozyme/PACAP
avoidance in Tetrahymena.
•The receptors in the two organisms exhibit very different
characteristics, including molecular weight, interaction with ligands, and
interaction with second messenger pathways.
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